Gridai Technologies Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.01

+0.37 (+10.16%)

As of May 16, 2:31 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +977.3% upside

Low Target $28.55

Average Target $43.20

High Target $44.32

Current Price $4.01

Current
$4.01

Target
$43.20

$28.55 $43.20 avg $44.32

Scenario Analysis

Bear Case

$28.55

612.0%

Low target

Base Case

$43.20

+977.3%

Avg target

Bull Case

$44.32

+1,005.2%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$5.84

-31.3% from high

52-Week Low

$1.06

+278.3% from low

Target vs 52W High

$43.20

+639.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%